Production (Stage)
Inovio Pharmaceuticals, Inc.
INO
$2.22
-$0.05-2.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -96.48M | -107.25M | -112.88M | -121.64M | -124.94M |
| Total Depreciation and Amortization | 3.11M | 3.13M | 2.53M | 2.80M | 3.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.24M | 2.71M | 3.70M | 15.06M | 17.95M |
| Change in Net Operating Assets | -6.59M | -2.67M | -4.05M | -8.57M | -12.59M |
| Cash from Operations | -102.19M | -104.08M | -110.69M | -112.36M | -116.46M |
| Capital Expenditure | -511.70K | -487.90K | -487.90K | -487.90K | -59.50K |
| Sale of Property, Plant, and Equipment | 59.30K | 59.30K | 148.30K | 148.30K | 148.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.09M | 104.50M | 89.71M | 70.14M | 113.65M |
| Cash from Investing | 58.64M | 104.07M | 89.37M | 69.80M | 113.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -16.42M | -16.42M | -16.42M | -16.42M |
| Issuance of Common Stock | 31.98M | 36.10M | 24.86M | 24.90M | 10.69M |
| Repurchase of Common Stock | -320.70K | -420.70K | -420.70K | -424.00K | -216.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.21M | 32.21M | 16.15M | 16.15M | -- |
| Cash from Financing | 63.87M | 51.48M | 24.17M | 24.21M | -5.94M |
| Foreign Exchange rate Adjustments | 0.00 | 32.40K | 32.90K | 30.80K | 30.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.31M | 51.50M | 2.88M | -18.32M | -8.64M |